Groundbreaking Advancement in Surgery of Cancer of Breast.
Nashik: Dr. Raj Nagarkar and his team at HCG Manavata Cancer Centre (HCGMCC) have made a groundbreaking advancement in cancer of breast surgery by performing the world’s first robotic-assisted nipple-sparing mastectomy (RNSM) using the Versius CMR system. The surgery was conduct recently on a 35-year-old woman who was diagnosis with breast cancer in March 2024.
Nipple-sparing mastectomy (NSM) traditionally involves removing the entire breast tissue, preserving the nipple, areola, and skin through a maximally invasive open surgical technique.
The HCG Manavata team has pioneered a ‘3 cm incision Scar’ approach using robotic assistance, enhancing precision and dexterity with 3D visualization. This method ensures complete mastectomy without compromising oncological safety and significantly improves cosmetic outcomes.
“The patient underwent eight cycles of chemotherapy followed by surgery in July 2024. Because her positive BRCA genetic mutation and family history of breast cancer.
It was necessary to remove her entire breast and nodes, along with the opposite breast and ovaries. She was discharge on the third day after surgery,” says Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC).
“The patient benefits of this procedure are astonishing. RNSM offers superior cosmetic results, preserving the nipple-areola complex. More importantly, the sensation of the nipple areola complex is not harmed. This leads to better body image, higher patient satisfaction, and improved psychological well-being. The minimally invasive technique results in less postoperative pain, quicker recovery, shorter hospital stays, and minimal scarring,” he adds.
HCGMCC on Cancer of Breast surgery
The RNSM was successfully performed by HCGMCC on a patient with early-stage cancer of breast, featuring a small primary tumor and no axillary node involvement. The procedure was followed by breast reconstruction surgery using autologous muscle and fat tissue from her back.
The team included Dr. Raj Nagarkar, Dr. Aditya Adhav, Dr. Rajendra Dhondge, Dr. Rajendra Bhamare, Dr. Utkarsh Asgaonkar, Dr. Praveen Surpur, and Dr. Palak Naik, with anaesthesia support from Dr. Ravindra Tandale and Dr. Jitendra Mahajan.
“This is a revolutionary procedure that marks a significant milestone in breast cancer treatment. The precision and minimally invasive nature of robotic-assisted surgery not only ensure oncological safety but enhance the overall patient experience. We at HCG Manavata Cancer Centre are the first ones in the world to perform RNSM on the Versius CMR (Robot) system. We are proud to be at the forefront of this medical advancement,” concludes Dr. Nagarkar.
Read Also – Fencer Nada Hafez To Serena Williams: 5 Women Who Dominated The Olympic Games While Pregnant
About HCG Manavata Cancer Centre (HCGMCC): –
Established in 2007 by Dr Raj Nagarkar, HCGMCC – Nashik is Central India’s first NABH-accredited facility. With over 50 consultant oncologists, 900 staff members and a 275-bed capacity, HCGMCC is a leading institution, offering holistic cancer treatment. Specializing in surgical, radiation and medical oncology, the centre has conducted 65,000 surgeries, including 1,000 plus robotic-assisted procedures. Patient-centric and multidisciplinary, HCGMCC recommends treatments to individual needs. Beyond clinical excellence, the centre’s financial aid programs underscore its commitment to accessibility and community well-being, redefining cancer care in the pursuit of a cancer-free future.
